Bei Zhang
Company: Novo Nordisk
Job title: Corporate Vice President
Seminars:
CagriSemi for Weight Management – From Discovery to the Clinic 9:00 am
CagriSema combines the actions of semaglutide and cagrilintide to improve several aspects of metabolism CagriSema displays dual efficacy of robust glycaemic control and body weight loss Weight loss of a higher magnitude contributes to additional glycaemic control and may have potential disease modifying effectsRead more
day: Conference Day 1